Recent advancements have significantly improved the identification of individuals at high risk of cardiovascular events and the management of their modifiable risk factors. However, there is increasing recognition that certain patient groups remain under-assessed and under-treated for their cardiovascular risks.
Join this meeting to explore how standard cardiovascular risk assessments can be enhanced for specific groups. Gain practical strategies for incorporating additional risk factors and effectively managing these risks to improve outcomes.
By attending, participants will learn to assess and manage the cardiovascular risk in:
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Amgen, Daiichi Sankyo, Novartis and Sanofi for their financial support of this meeting. None of the companies have had any input or control over the agenda or organisation of the meeting.
Chair: Dr Paul Flynn, President-Elect, Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Dr Paul Flynn
Professor Dorian Haskard, Professor of Cardiovascular Medicine and Rheumatology, Imperial College, London
Dr Sonia Raffe, Consultant in Sexual Health and HIV, The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Brighton
Chair: Professor Christian Heiss, President, Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Dr Paul Flynn, Consultant in Metabolic Medicine, Addenbrooke's Hospital, Cambridge
Dr Janaka Karalliedde, Clinical Senior Lecturer, School of Cardiovascular Medicine and Sciences, King’s College, London
Chair: Professor Andrew Krentz, Past President, Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Dr Paul Flynn, Consultant in Metabolic Medicine, Addenbrooke’s Hospital, Cambridge
Professor Chris Byrne, Professor of Endocrinology and Metabolism, University of Southampton
Chair: Dr Paul Flynn
Dr Devaki Nair, Consultant Chemical Pathologist, Royal Free Hospital, London
Dr Tina Khan, Consultant Cardiologist and Honorary Clinical Senior Lecturer, Imperial College, London
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registrations for this event will close on 31 March 2025 at 10:00am (GMT).
The agenda is subject to change at any time.
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM's discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
